[1] 朱频频,吴丹,李艺星,等.2022年8月世界卫生组织194个成员国百日咳疫苗免疫程序现状[J].中国疫苗和免疫,2022,28(6):650-658.
[2] Liang Y,Salim AM,Wu W,et al. Chao Yuanfang:Imperial physician of the sui dynasty and an early pertussis observer?[J].Open Forum Infect Dis,2016,3(1):ofw017.
[3] Cherry JD.The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States:A comparative study[J]. Curr Probl Pediatr,1984,14(2):1-78.
[4] 韩菲,吴春雪,徐汉云.婴幼儿百日咳综合征患儿68例临床特点分析[J].中国中西医结合儿科学,2019,11(6):512-515.
[5] Guimaraes LM,Gameir EL,Carvlho-Costa FA.Increasing incidence of pertussis in Brazil:A retrospective study using surveillance data[J]. BMC Infect Dis,2015,15:442.
[6] Préziosi MP,Yam A,Wassilak SG,et al.Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program[J]. Am J Epidemiol,2002,155(10):891-896
[7] 汪海波,罗会明,温宁,等.我国2006—2010年百日咳流行病学分析[J].中国疫苗和免疫,2012,18(3):207-210.
[8] 疾病预防控制局. 2017年6月全国法定传染病疫情况[EB/OL].(2017-07-12)[2024-02-01].http://www.nhc.gov.cn/xcs/fkdt/list_gzbd.shtml.
[9] 单鸣凤,谈华,梁宏露,等.48例婴儿百日咳的临床特征分析[J].分子诊断与治疗杂志,2022,14(7):1250-1254.
[10] Hanson MP,Kwan-Gett TS,Baer A,et al.Infant pertussis epidemiology and implications for tetanus toxoid,reduced diphtheria toxoid,and acellular pertussis(Tdap)vaccination[J]. Arch Pediatr Adolesc Med,2011,165(7):647-652.
[11] 吴小英,甘川. 婴幼儿重症百日咳死亡相关因素分析[J]. 临床儿科杂志,2020,38(6):432-437.
[12] Rendi-wagner P,Tobias J,Moerman L,et al.The seroepidemiology of Bordetella pertussis in Israel-Estimate of incidence of infection[J].Vaccine,2010,28(19):3285-3290.
[13] Macina D,Evans KE.Bordetella pertussis in school-age children,adolescents,and adults:A systematic review of epidemiology,burden,and mortality in Africa[J]. Infect Dis Ther,2021,10(3):1097-1113.
[14] Macina D,Evans KE.Bordetella pertussis in school-age children,adolescents,and adults:A systematic review of epidemiology,burden,and mortality in the middle east[J]. Infect Dis Ther,2021,10(2):719-738.
[15] 宁桂军,高源,吴丹,等. 中国2011—2017 年百日咳流行病学特征分析[J]. 中国疫苗和免疫,2018,24(3):264-267,273.
[16] 吴丹,郑徽,李明爽,等.中国2018—2021年百日咳流行病学特征[J].中国疫苗和免疫,2022,28(6):638-643.
[17] 徐颖华. 百日咳鲍特氏菌分子鉴定、基因组多态性与微进化的研究[D].北京:中国人民解放军军事医学科学院,2011:138.
[18] Bahmanjeh A,Noofeli M,Khaki P,et al.Genetic analysis of clinical and vaccine strains of Bordetella pertussis by pulsed-field gel electrophoresis (PFGE),multi locus sequence typing (MLST) and serotyping[J]. Comp Immunol Microbiol Infect Dis,2019,64:168-175.
[19] 医疗应急司. 关于印发鼠疫等传染病诊疗方案(2023年版)的通知[EB/OL].(2023-12-28)[2023-02-01]. http://www.nhc.gov.cn/ylyjs/pqt/202312/75cfff021a484d0c9c200f85f2bf746b.shtml.
[20] Winter K,Zipprich J,Harriman K,et al.Risk factors associated with infant deaths from pertussis:A case-control study[J]. Comp Immunol Microbiol Infect Dis,2015,61(7):1099-1106.
[21] Vtn N,Simon L.Pertussis:The whooping cough[J]. Primarycare, 2018,45(3) :423-431.
[22] 雷炎玲. 大环内酯类抗生素耐药与敏感百日咳的临床比较[D].遵义:遵义医科大学,2019:1-38.
[23] Hua CZ,Wang HJ,Zhang Z,et al.In vitro activity and clinical efficacy of macrolides,cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates:A single-centre study in Zhejiang Province,China[J]. J Glob Antimicrob Resist,2019,18:47-51.
[24] Wang K,Bettiol S,Thompson M J,et al. Symptomatic treatment of the cough in whooping cough[J]. Cochrane Database Syst Rev,2014,2014(9):Cd003257.
[25] Cherry JD,Wendorf K,Bregman B,et al.An observational study of severe pertussis in 100 infants ≤120 days of age[J]. Pediatr Infect Dis J,2018,37(3):202-205.
[26] Domico M,Ridout D,MacLaren G,et al. Extracorporeal membrane oxygenation for pertussis:Predictors of outcome including pulmonary hypertension and leukodepletion[J]. Pediatr Crit Care Med,2018,19(3):254-261.
[27] 李敏霞,王乔宇,曲东,等. 白细胞单采术治疗小儿重症百日咳合并高白细胞血症一例并文献复习[J]. 中国小儿急救医学,2020,27(4):312-313
[28] 吴小英,李丽君,姚开虎,等.儿童重症百日咳治疗策略研究进展[J].中国当代儿科杂志,2021,23(2):192-197.
[29] Locht C.The path to new pediatric vaccines against pertussis[J]. Vaccines (Basel),2021,9(3):228. |
粤公网安备 44011302000297号 